전기요법 시장 규모, 점유율, 동향 분석 보고서 : 치료법별, 용도별, 지역별, 부문별 예측(2025-2033년)

Electrotherapy Market Summary

The global electrotherapy market size was estimated at USD 1.38 billion in 2024 and is projected to reach USD 1.98 billion by 2033, growing at a CAGR of 4.12% from 2025 to 2033. The market is primarily driven by the rising prevalence of chronic pain, musculoskeletal disorders, and neurological conditions, which increase the demand for effective, non-invasive treatment options.

Technological advancements in portable and user-friendly devices, such as TENS and EMS units, have enhanced accessibility and improved patient compliance. The growing preference for drug-free and non-surgical pain management solutions is fueling market adoption.

An aging population, more prone to chronic ailments, further supports demand. Meanwhile, increasing awareness of physical therapy and rehabilitation, along with supportive healthcare initiatives and investments, is driving global market growth.

The growing prevalence of chronic diseases such as arthritis, diabetes, cardiovascular disorders, and chronic pain conditions is a major market driver. These long-term health issues often result in reduced mobility, muscle degeneration, and persistent pain, creating a strong demand for non-invasive and cost-effective therapeutic solutions. Electrotherapy modalities, including TENS, EMS, and NMES, are increasingly utilized to manage pain, improve muscle function, and enhance rehabilitation outcomes in patients with chronic conditions. The shift toward home-care and remote treatment options for chronic disease management further accelerates the adoption of portable and user-friendly electrotherapy devices worldwide.

Global Electrotherapy Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global electrotherapy market report based ontherapy type, application, end use, and region

• Therapy Type Outlook (Revenue, USD Million, 2021 - 2033)
• Transcutaneous Electrical Nerve Stimulation (TENS)
• Interferential Therapy (IFT)
• NMES/FES
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Nervous Disease
• Muscle Injury
• Inflammation
• Pain Relief
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Purchased database.
• 1.5. GVR's internal database
• 1.6. Secondary sources
• 1.7. Third Party Perspective
• 1.8. Primary research
• 1.9. Details of primary research
• 1.10. Information or Data Analysis
• 1.11. Data analysis models
• 1.12. Market Formulation & Validation
• 1.13. Model Details
• 1.14. Commodity flow analysis (Model 1)
• 1.15. Approach 1: Commodity flow approach
• 1.16. Volume price analysis (Model 2)
• 1.17. Approach 2: Volume price analysis
• 1.18. List of Secondary Sources
• 1.19. List of Primary Sources
• 1.20. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Electrotherapy Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing prevalence of chronic diseases and pain disorders
    • 3.2.1.2. Rising demand for non-invasive and drug-free pain management
    • 3.2.1.3. Growing awareness of physical therapy and rehabilitation
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of advanced devices
    • 3.2.2.2. Limited awareness and acceptance in certain regions
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Growing adoption of home healthcare
    • 3.2.3.2. Expanding applications in sports medicine
    • 3.2.3.3. Increased focus on non-pharmacological pain management
  • 3.2.4. Market Challenges Analysis
    • 3.2.4.1. Lack of clinical evidence for some modalities
    • 3.2.4.2. Competition from alternative therapies
• 3.3. Electrotherapy Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining Power of Suppliers
    • 3.3.1.2. Bargaining Power of Buyers
    • 3.3.1.3. Threat of Substitutes
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological Landscape

Chapter 4. Electrotherapy Market: Therapy Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Electrotherapy Market: Therapy Type Movement Analysis & Market Share, 2024 & 2033
• 4.3. Transcutaneous Electrical Nerve Stimulation (TENS)
  • 4.3.1. Transcutaneous Electrical Nerve Stimulation (TENS) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Interferential Therapy (IFT)
  • 4.4.1. Interferential Therapy (IFT) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. NMES/FES
    • 4.4.2.1. NMES/FES Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Others
    • 4.4.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Electrotherapy Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Electrotherapy Market: Application Movement Analysis & Market Share, 2024 & 2033
• 5.3. Nervous Disease
  • 5.3.1. Nervous Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Muscle Injury
  • 5.4.1. Muscle Injury Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Inflammation
  • 5.5.1. Inflammation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Pain Relief
  • 5.6.1. Pain Relief Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Electrotherapy Market: Regional Estimates & Trend Analysis by Therapy Type, Application, End Use

• 6.1. Regional Outlook
• 6.2. Electrotherapy Market: Regional Movement Analysis & Market Share, 2024 & 2033
• 6.3. North America
  • 6.3.1. North America Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. Key Country Dynamics
    • 6.3.2.2. Competitive Scenario
    • 6.3.2.3. Regulatory Scenario
    • 6.3.2.4. Reimbursement Scenario
    • 6.3.2.5. U.S. Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Canada
    • 6.3.3.1. Key Country Dynamics
    • 6.3.3.2. Competitive Scenario
    • 6.3.3.3. Regulatory Scenario
    • 6.3.3.4. Reimbursement Scenario
    • 6.3.3.5. Canada Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.4. Mexico
    • 6.3.4.1. Key Country Dynamics
    • 6.3.4.2. Competitive Scenario
    • 6.3.4.3. Regulatory Scenario
    • 6.3.4.4. Reimbursement Scenario
    • 6.3.4.5. Mexico Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Europe
  • 6.4.1. Europe Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.2. UK
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Competitive Scenario
    • 6.4.2.3. Regulatory Scenario
    • 6.4.2.4. Reimbursement Scenario
    • 6.4.2.5. UK Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.3. Germany
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Competitive Scenario
    • 6.4.3.3. Regulatory Scenario
    • 6.4.3.4. Reimbursement Scenario
    • 6.4.3.5. Germany Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.4. France
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Competitive Scenario
    • 6.4.4.3. Regulatory Scenario
    • 6.4.4.4. Reimbursement Scenario
    • 6.4.4.5. France Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.5. Italy
    • 6.4.5.1. Key Country Dynamics
    • 6.4.5.2. Competitive Scenario
    • 6.4.5.3. Regulatory Scenario
    • 6.4.5.4. Reimbursement Scenario
    • 6.4.5.5. Italy Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.6. Spain
    • 6.4.6.1. Key Country Dynamics
    • 6.4.6.2. Competitive Scenario
    • 6.4.6.3. Regulatory Scenario
    • 6.4.6.4. Reimbursement Scenario
    • 6.4.6.5. Spain Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.7. Denmark
    • 6.4.7.1. Key Country Dynamics
    • 6.4.7.2. Competitive Scenario
    • 6.4.7.3. Regulatory Scenario
    • 6.4.7.4. Reimbursement Scenario
    • 6.4.7.5. Denmark Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.8. Sweden
    • 6.4.8.1. Key Country Dynamics
    • 6.4.8.2. Competitive Scenario
    • 6.4.8.3. Regulatory Scenario
    • 6.4.8.4. Reimbursement Scenario
    • 6.4.8.5. Sweden Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.9. Norway
    • 6.4.9.1. Key Country Dynamics
    • 6.4.9.2. Competitive Scenario
    • 6.4.9.3. Regulatory Scenario
    • 6.4.9.4. Reimbursement Scenario
    • 6.4.9.5. Norway Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Asia Pacific Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.2. Japan
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Scenario
    • 6.5.2.4. Reimbursement Scenario
    • 6.5.2.5. Japan Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.3. China
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Scenario
    • 6.5.3.4. Reimbursement Scenario
    • 6.5.3.5. China Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.4. India
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Scenario
    • 6.5.4.4. Reimbursement Scenario
    • 6.5.4.5. India Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.5. South Korea
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Competitive Scenario
    • 6.5.5.3. Regulatory Scenario
    • 6.5.5.4. Reimbursement Scenario
    • 6.5.5.5. South Korea Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.6. Australia
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Competitive Scenario
    • 6.5.6.3. Regulatory Scenario
    • 6.5.6.4. Reimbursement Scenario
    • 6.5.6.5. Australia Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.7. Thailand
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Competitive Scenario
    • 6.5.7.3. Regulatory Scenario
    • 6.5.7.4. Reimbursement Scenario
    • 6.5.7.5. Thailand Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Latin America
  • 6.6.1. Latin America Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.2. Brazil
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Scenario
    • 6.6.2.4. Reimbursement Scenario
    • 6.6.2.5. Brazil Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.3. Argentina
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Scenario
    • 6.6.3.4. Reimbursement Scenario
    • 6.6.3.5. Argentina Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Middle East & Africa
  • 6.7.1. Middle East & Africa Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.2. South Africa
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Scenario
    • 6.7.2.4. Reimbursement Scenario
    • 6.7.2.5. South Africa Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.3. Saudi Arabia
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Scenario
    • 6.7.3.4. Reimbursement Scenario
    • 6.7.3.5. Saudi Arabia Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.4. UAE
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Scenario
    • 6.7.4.4. Reimbursement Scenario
    • 6.7.4.5. UAE Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.5. Kuwait
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory Scenario
    • 6.7.5.4. Reimbursement Scenario
    • 6.7.5.5. Kuwait Electrotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. Medtronic
    • 7.2.1.1. Company Overview
    • 7.2.1.2. Financial Performance
    • 7.2.1.3. Product Benchmarking
    • 7.2.1.4. Strategic Initiatives
  • 7.2.2. Zynex Medical
    • 7.2.2.1. Company Overview
    • 7.2.2.2. Financial Performance
    • 7.2.2.3. Product Benchmarking
    • 7.2.2.4. Strategic Initiatives
  • 7.2.3. BTL Group of Companies
    • 7.2.3.1. Company Overview
    • 7.2.3.2. Financial Performance
    • 7.2.3.3. Product Benchmarking
    • 7.2.3.4. Strategic Initiatives
  • 7.2.4. Omron Healthcare, Inc.
    • 7.2.4.1. Company Overview
    • 7.2.4.2. Financial Performance
    • 7.2.4.3. Product Benchmarking
    • 7.2.4.4. Strategic Initiatives
  • 7.2.5. NeuroMetrix, Inc.
    • 7.2.5.1. Company Overview
    • 7.2.5.2. Financial Performance
    • 7.2.5.3. Product Benchmarking
    • 7.2.5.4. Strategic Initiatives
  • 7.2.6. GymnaUniphy
    • 7.2.6.1. Company Overview
    • 7.2.6.2. Financial Performance
    • 7.2.6.3. Product Benchmarking
    • 7.2.6.4. Strategic Initiatives
  • 7.2.7. Enovis Corporation
    • 7.2.7.1. Company Overview
    • 7.2.7.2. Financial Performance
    • 7.2.7.3. Product Benchmarking
    • 7.2.7.4. Strategic Initiatives
  • 7.2.8. Omron Healthcare, Inc.
    • 7.2.8.1. Company Overview
    • 7.2.8.2. Financial Performance
    • 7.2.8.3. Product Benchmarking
    • 7.2.8.4. Strategic Initiatives
  • 7.2.9. Stymco
    • 7.2.9.1. Company Overview
    • 7.2.9.2. Financial Performance
    • 7.2.9.3. Product Benchmarking
    • 7.2.9.4. Strategic Initiatives
  • 7.2.10. RS Medical
    • 7.2.10.1. Company Overview
    • 7.2.10.2. Financial Performance
    • 7.2.10.3. Product Benchmarking
    • 7.2.10.4. Strategic Initiatives
  • 7.2.11. Orthofix Medical
    • 7.2.11.1. Company Overview
    • 7.2.11.2. Financial Performance
    • 7.2.11.3. Product Benchmarking
    • 7.2.11.4. Strategic Initiatives
  • 7.2.12. Haifu
    • 7.2.12.1. Company Overview
    • 7.2.12.2. Financial Performance
    • 7.2.12.3. Product Benchmarking
    • 7.2.12.4. Strategic Initiatives
• 7.3. Company Market Share Analysis, 2024